Protein biomarkers are central to translational and clinical neurobiology research. Yet, many established neurological biomarkers only capture a partial picture of biology driving neurological processes and diseases, especially when used in isolation. High-specificity proteomics can help you explore new protein signatures and patterns with translational potential.
Explore protein patterns associated with neurodegeneration, neuroinflammation, psychiatric disorders, and more.
Investigate the complex pathways governing neurological signaling, glial activation, neurogenesis, and other key processes.
Discover multi-protein signatures and investigate their potential for diagnosis, monitoring, and stratification in clinical research.
Investigate how individual heterogeneity may help to influence disease processes and potentially treatment responses.
Progress in neurological biomarker research depends on moving beyond established CNS biomarkers towards a broader systems-biology view, supported by technology that delivers specificity, sensitivity, scalability, and reproducibility. Olink helps you explore neurobiology with exceptional biological breadth and depth, measure low abundance signals in blood and cerebral spinal fluid (CSF), and move from discovery toward translational follow-up all with the same technology platform.
Research need
How Olink proteomics supports it
Broad proteomic coverage enables exploration of pathways beyond established neurological biomarkers.
High specificity and sensitivity support reliable detection of low-abundance biomarkers across plasma, CSF, and beyond from as little as 1 μL of sample.
The Olink platform supports large-scale biomarker discovery, focused biomarker follow-up, and cohort-based translational research with robust data quality and throughout.
Compare new findings against existing population-scale proteomics datasets and annotations to strengthen biological evidence and guide follow-up research.
Get started easily with assays that fit into existing workflows.
Leverage Olink experts or global Service Providers to help ensure your study’s success.
From uncovering complex disease biology and early drivers of neurological disease to identifying emerging biomarker candidates and generating real-world evidence, explore how researchers are using Olink solutions to push the boundaries of neurological research.
Hear leading experts across biopharma and academia discuss the latest advancements, challenges, and opportunities in the field of neurological biomarker research. Their discussion covers the progress that has been made, key lessons learned, and what lies ahead in discovery and implementation.
Informed by a roundtable discussion with leading experts from academia and biopharma, this white paper examines what is working, what remains challenging, and the practical lessons learned in applying biomarker research to advance precision approaches in neurology.
Watch researchers across the neurological disease continuum present recent findings.
Testimonials
Hear from researchers using Olink solutions to advance their neurobiology research across neurodegeneration, dementia, and translational programs.
Explore recent discoveries and emerging advances in neurological biomarker research—from large-scale proteomics studies and novel disease insights to the translational applications that have the potential to shape the future of neurology.
Below are a few documents highlighting how PEA technology is being applied to tackle the complexity of neurological disease research.
| Documents | Type | File |
|---|---|---|
| Insights from precious samples in neurology research | Flyer | Download PDF |
| Performance of Olink® Explore 3072 in Brain Tissue Lysates technical note | Technical note | Download PDF |
| Multiomics at the Frontline of Neurology Research | Customer interview | Download PDF |
| Emerging Dementia Biofluid Biomarker Candidates Identified in Human Proteomic Studies (2021-2025) | Data resource | Download PDF |
Olink’s scalable technology provides optimized solutions for every stage of the biomarker workflow, from high-throughput discovery through validation and clinical utility.
Whether you are looking for full-service sample analysis, support from a Certified Service Provider, or want to run the assays in your own lab, you can access Olink solutions in a way that fits your study designs and infrastructure needs.
